Balancing Safety and Speed

Bob and Hanne discuss the delicate balance between safety and urgency in drug approval, citing the AIDS epidemic and the Viox situation as pivotal moments for the FDA. They explore the tension between doing no harm and doing the most good, and how rethinking healthcare can lead to better outcomes for patients.